Acalabrutinib

An orally available inhibitor of Bruton’s tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, acalabrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B lymphocyte development, activation, signaling, proliferation and survival. (NCI Dictionary)

YOU MAY ALSO LIKE

Acai Berry Juice

A juice product obtained from the fruit of the acai palm tree (Euterpe oleracea) with anti-inflammatory, antioxidant and potential chemopreventive activities. Besides…

ACADS wt Allele

Human ACADS wild-type allele is located within 12q22-qter and is approximately 14 kb in length. This allele, which encodes short-chain specific acyl-CoA…

ACADS Gene

This gene plays a role in lipid metabolism.

ACADM wt Allele

Human ACADM wild-type allele is located in the vicinity of 1p31 and is approximately 39 kb in length. This allele, which encodes…

ACADM Gene

This gene is involved in lipid metabolism.

Acadesine

A 5-aminoimidazole-4-carboxamide (AICA) riboside, a ribnucleoside analog, and a nucleotide biosynthesis precursor with B cell pro-apoptotic activity. Following cellular uptake, acadesine is…